ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,262.08
1.38%
Dow Jones
44,296.51
0.97%
Gold vs US Dollar
2,715.28
0.00%
Brent Oil
74.65
0.00%
Bitcoin
98,191.92
0.42%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Mei Pharma, Inc. (MM) (MSHL)

  7. Mei Pharma, Inc. (MM) (MSHL) News

Marshall Edwards (MSHL)

Mei Pharma, Inc. (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MSHL
DateTimeSourceHeadlineSymbolCompany
09/07/201218:41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MSHLMei Pharma, Inc. (MM)
05/07/201220:03Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(3) (424B3)NASDAQ:MSHLMei Pharma, Inc. (MM)
02/07/201219:18Edgar (US Regulatory)Current report filing (8-K)NASDAQ:MSHLMei Pharma, Inc. (MM)
28/06/201213:00PR Newswire (US)Marshall Edwards Announces Name Change to MEI Pharma ("MEIP")NASDAQ:MSHLMei Pharma, Inc. (MM)
06/06/201210:04Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(3) (424B3)NASDAQ:MSHLMei Pharma, Inc. (MM)
05/06/201221:28Edgar (US Regulatory)Current report filing (8-K)NASDAQ:MSHLMei Pharma, Inc. (MM)
04/06/201213:00PR Newswire (US)Marshall Edwards Presents Results From Clinical Trial Of Lead Oncology Drug Candidate ME-143NASDAQ:MSHLMei Pharma, Inc. (MM)
29/05/201213:00PR Newswire (US)Marshall Edwards Announces First Cohort Of Patients Dosed In Phase I Clinical Trial Of Oncology Drug Candidate ME-344NASDAQ:MSHLMei Pharma, Inc. (MM)
25/05/201217:32Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:MSHLMei Pharma, Inc. (MM)
15/05/201219:27Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(3) (424B3)NASDAQ:MSHLMei Pharma, Inc. (MM)
15/05/201217:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MSHLMei Pharma, Inc. (MM)
15/05/201217:13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MSHLMei Pharma, Inc. (MM)
15/05/201217:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MSHLMei Pharma, Inc. (MM)
15/05/201214:05Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:MSHLMei Pharma, Inc. (MM)
14/05/201213:00PR Newswire (US)Marshall Edwards Completes Rights Offering To StockholdersNASDAQ:MSHLMei Pharma, Inc. (MM)
08/05/201213:00PR Newswire (US)Marshall Edwards Receives $4 Million Subscription From Novogen In Rights OfferingNASDAQ:MSHLMei Pharma, Inc. (MM)
25/04/201213:00PR Newswire (US)Marshall Edwards Issued New Patent For Use Of Lead Drug Candidate ME-143 In Treating CancerNASDAQ:MSHLMei Pharma, Inc. (MM)
13/04/201219:59Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(3) (424B3)NASDAQ:MSHLMei Pharma, Inc. (MM)
11/04/201218:41Edgar (US Regulatory)Current report filing (8-K)NASDAQ:MSHLMei Pharma, Inc. (MM)
10/04/201213:00PR Newswire (US)Marshall Edwards Receives FDA Approval of Investigational New Drug Application for Clinical Testing of Oncology Drug Candidat...NASDAQ:MSHLMei Pharma, Inc. (MM)
03/04/201213:00PR Newswire (US)Marshall Edwards Announces Data from Clinical Trial of ME-143 Selected for Presentation at ASCO Annual MeetingNASDAQ:MSHLMei Pharma, Inc. (MM)
30/03/201216:34Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(3) (424B3)NASDAQ:MSHLMei Pharma, Inc. (MM)
30/03/201216:32Edgar (US Regulatory)Current report filing (8-K)NASDAQ:MSHLMei Pharma, Inc. (MM)
28/03/201213:00PR Newswire (US)Marshall Edwards CEO to Present at Needham Healthcare ConferenceNASDAQ:MSHLMei Pharma, Inc. (MM)
27/03/201213:00PR Newswire (US)Marshall Edwards Receives Notice of Effectiveness for Rights Offering to StockholdersNASDAQ:MSHLMei Pharma, Inc. (MM)
27/03/201210:02Edgar (US Regulatory)Notice of Effectiveness (EFFECT)NASDAQ:MSHLMei Pharma, Inc. (MM)
26/03/201220:40Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(3) (424B3)NASDAQ:MSHLMei Pharma, Inc. (MM)
20/03/201212:55Edgar (US Regulatory)Securities Registration Statement (S-1/A)NASDAQ:MSHLMei Pharma, Inc. (MM)
19/03/201213:00PR Newswire (US)Marshall Edwards Announces Terms for Rights Offering to StockholdersNASDAQ:MSHLMei Pharma, Inc. (MM)
07/03/201217:17Edgar (US Regulatory)Current report filing (8-K)NASDAQ:MSHLMei Pharma, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:MSHL

Your Recent History

LSE
POS
Plexus
LSE
VAST
Vast Resources
LSE
GKP
Gulf Keystone Petroleum
LSE
ZED
Zenova
LSE
ROCK
Rockfire Resources
LSE
NFDS
Northern Foods
LSE
GOLD
LSE
SCLP
Scancell
LSE
TERN
Tern
LSE
THG
Thg
LSE
THUS
Thus
LSE
LLOY
Lloyds Banking
LSE
FUM
Futura Medical
LSE
MAST
Mast Energy Developments
LSE
BARC
Barclays
LSE
QBT
Quantum Blockchain Techn...
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    BLACK FRIDAY

    ADVFN

    Celebrating 25 years Est 1999-2024

    Save up to 60%* for Silver

    1 year 40%, 2 years 50% and *3 years 60%

    *Across 3 years £903.96 only 361.58